Edward H Leiter
Overview
Explore the profile of Edward H Leiter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Daneshgari F, Leiter E, Liu G, Reeder J
J Urol
. 2009 Oct;
182(6 Suppl):S8-13.
PMID: 19846143
Purpose: Diabetes mellitus is a group of debilitating and costly diseases with multiple serious complications. Lower urinary tract complications or diabetic uropathy are among the most common complications of diabetes...
12.
Brosius 3rd F, Alpers C, Bottinger E, Breyer M, Coffman T, Gurley S, et al.
J Am Soc Nephrol
. 2009 Sep;
20(12):2503-12.
PMID: 19729434
Diabetic nephropathy is a major cause of ESRD worldwide. Despite its prevalence, a lack of reliable animal models that mimic human disease has delayed the identification of specific factors that...
13.
Leiter E
Methods Mol Biol
. 2009 Jun;
560:1-17.
PMID: 19504239
This is not a "Methods" chapter in the traditional sense. Rather, it is an essay designed to help address one of the most frequently asked questions by investigators about to...
14.
Su Z, Ishimori N, Chen Y, Leiter E, Churchill G, Paigen B, et al.
J Lipid Res
. 2009 May;
50(10):2083-94.
PMID: 19436067
To identify genes controlling plasma HDL and triglyceride levels, quantitative trait locus (QTL) analysis was performed in one backcross, (NZO/H1Lt x NON/LtJ) x NON/LtJ, and three intercrosses, C57BL/6J x DBA/2J,...
15.
16.
Leiter E, Reifsnyder P, Wallace R, Li R, King B, Churchill G
Diabetes
. 2009 Apr;
58(7):1700-3.
PMID: 19336673
Objective: Introduction of genes targeted in 129/Sv embryonic stem (ES) cells into NOD mice brings about linked genes that may modulate type 1 diabetes. Our objective was to identify 129S1/SvJ...
17.
Reifsnyder P, Schott W, Pomerleau D, Lessard M, Soper B, Leiter E
Novartis Found Symp
. 2009 Feb;
292:32-46.
PMID: 19203091
The major histocompatibility complex (MHC) of the type 1 diabetes-prone NOD mouse lacks a functional class II H2-Ea gene such that antigen presenting cells (APCs) are I-E null. Transgenic expression...
18.
Chen J, Lu Y, Lee C, Li R, Leiter E, Mathews C
Free Radic Biol Med
. 2008 Aug;
45(9):1263-70.
PMID: 18718526
ALR/Lt, a NOD-related mouse strain, was selected for resistance to alloxan free radical-mediated diabetes (ALD). Despite extensive genomic identity with NOD (>70%), ALR mice display strong resistance to autoimmune type...
19.
Leiter E
Curr Protoc Immunol
. 2008 Apr;
Chapter 15:15.9.1-15.9.23.
PMID: 18432739
Nonobese diabetic (NOD) mice spontaneously develop autoimmune T cell-mediated insulin-dependent diabetes mellitus (IDDM). This unit presents a protocol for maintaining NOD mice under conditions permissive to full expression of their...
20.
Miller A, Komak S, Webb M, Leiter E, Thompson E
Cancer Cell Int
. 2007 Nov;
7:18.
PMID: 18045478
Background: Glucocorticoids (GC's) play an integral role in treatment strategies designed to combat various forms of hematological malignancies. GCs also are powerful inhibitors of the immune system, through regulation of...